“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...

Moderna advances combo vaccine for flu and COVID-19 with trials starting in March Pharmaceutical companies gear up to tackle ...

MRNA-1273.213 is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

The intervening years have both sped and crawled by, too busy at times to take stock of all that has changed, too plodding to ...

A key feature of the mRNA vaccine platform is that it is flexible and fast. Whereas the strains that go into flu shots have to be selected in February so that vaccine manufacturers have enough ...

CureVac shares have been volatile over the past week, gaining some 25%. The stock has seen increased trading volume following ...

Dr Wiklund noted that: “mRNA is particularly relevant to individualised cancer vaccines because it is a highly adaptable molecular platform. We have seen encouraging data with Moderna’s ...

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest ...

With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often ...